<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03976934</url>
  </required_header>
  <id_info>
    <org_study_id>1725</org_study_id>
    <nct_id>NCT03976934</nct_id>
  </id_info>
  <brief_title>Prophylactic Administration of Alpha Blockers for Prevention of Urinary Retention in Males Undergoing Inguinal Hernia Repair Under Spinal Anaesthesia.</brief_title>
  <official_title>Prophylactic Administration of Alpha Blockers for Prevention of Post Operative Urinary Retention in Males Undergoing Open Inguinal Hernia Repair Under Spinal Anaesthesia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgios Koukoulis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Thessaly</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>General Hospital of Larissa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open inguinal hernia repair is one of the most common surgical procedures. Despite the fact
      that different of anesthetic procedures are proposed as alternatives to spinal anesthesia,
      the combination of spinal anesthesia with open inguinal hernia repair is preferred from both
      surgeons and patients. One disadvantage of this combination is the high incidence of
      post-surgery urinary retention, especially in men above 50 years old. This complication is
      partially attribute to overstimulation of the a1 adrenergic receivers of the bladder and the
      prostate. Preoperative administration of elective a1 blockers could inhibit this effect
      without side effects, since this drugs don't have systemic effect.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of urinary retention</measure>
    <time_frame>8 hours post surgery</time_frame>
    <description>inability to voluntarily void urine up to 8 hours post surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prostate related Symptoms</measure>
    <time_frame>Baseline</time_frame>
    <description>identification of Prostate related Symptoms as preoperative risk factor of post surgery urinary retention. For the assessment of the prostate related symptomatology will be used the International Prostate Symptom Score questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scrotal hernia Repair</measure>
    <time_frame>Baseline, Inta-operative</time_frame>
    <description>evaluation of Scrotal hernia repair as preoperative risk factor of post surgery urinary retention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Surgery</measure>
    <time_frame>Duration of Surgical procedure</time_frame>
    <description>Evaluation of the surgery duration as inta-operative risk factor of post surgery urinary retention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of opioids</measure>
    <time_frame>24 hours</time_frame>
    <description>Evaluation of the peri-operative administration of iv opioids as a peri-operative risk factor of post surgery urinary retention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iv fluid administration</measure>
    <time_frame>24 hours</time_frame>
    <description>Evaluation of the peri-operative iv fluid administration as a peri-operative risk factor of post surgery urinary retention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative Pain</measure>
    <time_frame>24 hours</time_frame>
    <description>Evaluation of the post operative pain as a risk factor of post surgery urinary retention. For the assessment of the pain will be used the Visual Analog Scale (VAS) score at 6, 12 and 24 hours after surgery. (VAS Score Scale from 0-10, 0 no pain, 10 max pain)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Urinary Retention</condition>
  <arm_group>
    <arm_group_label>Tamsulosin group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>administration of 0,4mg of tamsulosin 24 hours before surgery and 0,4mg 6 hours before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>administration of placebo 24 and 6 hours before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tamsulosin</intervention_name>
    <description>administration of tamsulosin tablets</description>
    <arm_group_label>Tamsulosin group</arm_group_label>
    <other_name>omnic tocas</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo oral tablet</intervention_name>
    <description>sugar pills</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unilateral inguinal hernia

        Exclusion Criteria:

          -  ASA score &gt;3

          -  hypotension

          -  prostatic hypertrophy

          -  complicated inguinal hernia

          -  neurological diseases

          -  inguinal hernia repair under general or local anaesthesia
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Konstantinos Tepetes, MD, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital of Larisa and Medical School, University of Thessaly</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georgios D Koukoulis, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital of Larissa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Konstantinos Mpouliaris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital of Larissa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Georgios D Koukoulis, MD, PhD</last_name>
    <phone>+30 241304366</phone>
    <email>georgios.koukoulis@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University General Hospital of Larissa</name>
      <address>
        <city>Larissa</city>
        <zip>41110</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Konstantinos Tepetes, MD</last_name>
      <email>tepetesk@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital Of Larissa</name>
      <address>
        <city>Larissa</city>
        <zip>41221</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgios Koukoulis, MD</last_name>
      <email>georgios.koukoulis@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Clancy C, Coffey JC, O'Riordain MG, Burke JP. A meta-analysis of the efficacy of prophylactic alpha-blockade for the prevention of urinary retention following primary unilateral inguinal hernia repair. Am J Surg. 2018 Aug;216(2):337-341. doi: 10.1016/j.amjsurg.2017.02.017. Epub 2017 Mar 14. Review.</citation>
    <PMID>28341140</PMID>
  </reference>
  <reference>
    <citation>Basheer A, Alsaidi M, Schultz L, Chedid M, Abdulhak M, Seyfried D. Preventive effect of tamsulosin on postoperative urinary retention in neurosurgical patients. Surg Neurol Int. 2017 May 10;8:75. doi: 10.4103/sni.sni_5_17. eCollection 2017.</citation>
    <PMID>28584678</PMID>
  </reference>
  <reference>
    <citation>Shaw MK, Pahari H. The role of peri-operative use of alpha-blocker in preventing lower urinary tract symptoms in high risk patients of urinary retention undergoing inguinal hernia repair in males above 50 years. J Indian Med Assoc. 2014 Jan;112(1):13-4, 16.</citation>
    <PMID>25935942</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 31, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>February 3, 2020</last_update_submitted>
  <last_update_submitted_qc>February 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>General Hospital of Larissa</investigator_affiliation>
    <investigator_full_name>Georgios Koukoulis</investigator_full_name>
    <investigator_title>General Surgery Consultant</investigator_title>
  </responsible_party>
  <keyword>open inguinal hernia repair</keyword>
  <keyword>spinal anaesthesia</keyword>
  <keyword>urinary retention</keyword>
  <keyword>elective alpha blockers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Retention</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tamsulosin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

